Stock events for HCA Healthcare, Inc. (HCA)
HCA Healthcare's stock price has increased by 27.78% in the past six months. As of June 24, 2025, the share price was $379.02, an 11.33% increase from June 25, 2024. The stock has also shown a 12.82% increase over the past three months and a 3.09% increase in the past month as of June 11, 2025. HCA Healthcare has scheduled its Q2 2025 Earnings Conference Call for July 25, 2025.
Demand Seasonality affecting HCA Healthcare, Inc.’s stock price
Demand for HCA Healthcare's services is influenced by seasonal factors, with the company anticipating a return to normal seasonal volume trends after COVID-19 disruptions. Volume, admission, and case-mix trends are affected by illnesses like influenza and weather conditions. Elective procedures and higher-acuity surgical volumes drive demand, and the company experiences seasonal surges requiring workforce forecasting and on-demand staffing.
Overview of HCA Healthcare, Inc.’s business
HCA Healthcare, Inc., founded in 1968 and headquartered in Nashville, Tennessee, is an American for-profit operator of healthcare facilities. It operates within the Healthcare sector, specifically in the Hospital/Nursing Management and Healthcare Facilities industries, and is one of the largest healthcare providers in the United States. HCA Healthcare provides inpatient and outpatient care, specialized care facilities, diagnostic and ancillary services, and treatment for various diseases. It is also a significant provider of clinical and medical education and offers cancer care through the Sarah Cannon Cancer Institute.
HCA’s Geographic footprint
HCA Healthcare operates extensively across the United States and the United Kingdom. As of December 31, 2024, it includes 190 hospitals and approximately 2,400 ambulatory sites across 21 states and the UK, with a strong presence in the southern U.S., particularly in Texas and Florida. It also has a notable presence in Tennessee, Virginia, and North Carolina.
HCA Corporate Image Assessment
HCA Healthcare has received positive recognition for ethical practices and admiration, including being named one of the World's Most Ethical Companies by Ethisphere and ranking first in its industry on Fortune's list of World's Most Admired Companies. However, the company has faced challenges, including protests by nurses over patient care concerns and scrutiny over patient care conditions, as well as an FTC lawsuit to block an acquisition due to anti-competitive concerns and criticism from Florida lawmakers regarding substandard patient care.
Ownership
HCA Healthcare has a significant number of institutional owners and shareholders, with 2139 institutions holding 63.00% of the company's shares. Major institutional owners include Vanguard Group Inc and BlackRock, Inc. Individual ownership is also substantial, with HCA Healthcare insiders owning 579.65% of the stock. The Frist family, the founders of HCA, are among the largest individual shareholders, owning approximately 25% of the company's shares. Patricia F. Elcan is noted as the largest individual shareholder, holding 83.67% of the company.
Ask Our Expert AI Analyst
Price Chart
$383.10